Branded pharmaceutical products, including branded generics, continue to hold significant market positions in India and international markets despite the rise of generic medicine use driven by healthcare cost pressures, formulary management by payers and governments, and evidence of generic bioequivalence.
Article Content
Branded pharmaceutical products, including branded generics, continue to hold significant market positions in India and international markets despite the rise of generic medicine use. The trend is driven by healthcare cost pressures, formulary management by payers and governments, and growing evidence of generic bioequivalence.
- The rise of generic medicine use is a defining trend in global pharmaceutical markets.
- Healthcare cost pressures are a major driver of generic medicine adoption.
- Formulary management by payers and governments influences the shift toward generics.
- Growing evidence supports the bioequivalence of generic medicines.
- Branded generics are a category that continues to command market share.
Frequently Asked Questions
What is the main topic of this article?
The article explains why branded pharmaceuticals, including branded generics, continue to command market share despite the growth of generic medicines.
Who wrote this article?
The article is authored by Shopify API.
When was this article published?
The article was published on 2026-08-23.
What role do branded generics play in the market?
Branded generics are a category that continues to hold significant market positions despite the overall rise of generic medicine use.
